Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

[ADDH drugs and heart failure. A reasonable assessment of risks and profits has to be made].

Lund LH.

Lakartidningen. 2012 Nov 7-13;109(45):2012. Swedish. No abstract available.

PMID:
23240308
2.

Drugs and A.D.H.D.

Blansfield HN.

Conn Med. 2000 Jun;64(6):355-6. Review. No abstract available.

PMID:
10909199
3.

The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.

Diller LH.

Hastings Cent Rep. 1996 Mar-Apr;26(2):12-8. Review. No abstract available.

PMID:
8722521
4.

A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.

Varley CK.

Psychopharmacol Bull. 1985;21(2):216-21. Review. No abstract available.

PMID:
2860692
5.

Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.

Gadow KD, Sverd J.

J Dev Behav Pediatr. 1990 Oct;11(5):269-71; discussion 272. Review. No abstract available.

PMID:
1979565
6.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
7.

Pharmacologic treatment of attention deficit hyperactivity disorder.

Greenhill LL.

Psychiatr Clin North Am. 1992 Mar;15(1):1-27. Review.

PMID:
1347936
8.

Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.

Merkel RL Jr, Kuchibhatla A.

Expert Opin Drug Saf. 2009 Nov;8(6):655-68. doi: 10.1517/14740330903279956. Review.

PMID:
19785509
9.

Clinical management of attention deficit hyperactivity disorder.

Voeller KK.

J Child Neurol. 1991;6 Suppl:S51-67. Review.

PMID:
1672134
10.

ADHD treatment and the risk of substance abuse.

Sircy RA, Stojanoski A.

Nurse Pract. 2008 Apr;33(4):33-6. doi: 10.1097/01.NPR.0000314755.03293.11. Review. No abstract available.

PMID:
18388552
11.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Dec;(8):280-90. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):318-27.

PMID:
12603883
12.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Jun;(7):262-71. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):280-90.

PMID:
12230649
13.

Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.

Rapoport JL, Inoff-Germain G.

J Atten Disord. 2002;6 Suppl 1:S57-60. Review.

PMID:
12685519
14.

[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

Golubchik P, Sever J, Weizman A.

Harefuah. 2011 Oct;150(10):788-90, 814. Review. Hebrew.

PMID:
22111124
15.

Treatment of attention-deficit/hyperactivity disorder.

Pierce K.

Pediatr Ann. 2011 Nov;40(11):556-62. doi: 10.3928/00904481-20111007-06. Review. No abstract available.

PMID:
22066507
16.

Pharmacotherapy of attention-deficit hyperactivity disorder.

Simeon JG, Wiggins DM.

Can J Psychiatry. 1993 Aug;38(6):443-8. Review.

PMID:
8104678
17.

Pemoline-associated hepatic failure: a critical analysis of the literature.

Shevell M, Schreiber R.

Pediatr Neurol. 1997 Jan;16(1):14-6. Review.

PMID:
9044395
18.

Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.

Kraemer M, Uekermann J, Wiltfang J, Kis B.

Clin Neuropharmacol. 2010 Jul;33(4):204-6. doi: 10.1097/WNF.0b013e3181e29174. Review.

PMID:
20571380
19.

[Is drug therapy of hyperactive children justified?].

Janols LO, von Knorring AL.

Lakartidningen. 1991 Sep 18;88(38):3057-8, 3061. Review. Swedish. No abstract available.

PMID:
1681156

Supplemental Content

Support Center